Amphastar P Stock Performance
| AMPH Stock | USD 20.23 6.26 23.63% |
The firm shows a Beta (market volatility) of 1.99, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Amphastar will likely underperform. At this point, Amphastar P has a negative expected return of -0.37%. Please make sure to confirm Amphastar's accumulation distribution, and the relationship between the value at risk and day typical price , to decide if Amphastar P performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Amphastar P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (23.63) | Five Day Return (28.82) | Year To Date Return (23.54) | Ten Year Return 80.63 | All Time Return 131.2 |
1 | Disposition of 2426 shares by Petersen Floyd F. of Amphastar at 25.9226 subject to Rule 16b-3 | 12/12/2025 |
2 | A Fresh Look at Amphastar Pharmaceuticals Valuation After Recent Share Price Stabilisation | 12/23/2025 |
3 | Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compou... | 01/12/2026 |
4 | 1 Profitable Stock Worth Your Attention and 2 Facing Headwinds - The Globe and Mail | 01/13/2026 |
5 | Why Amphastar Pharmaceuticals Stock Is Nosediving | 01/15/2026 |
6 | CorMedix vs. Mirum Pharma Which Rare-Disease Stock is the Better Buy | 01/20/2026 |
7 | CRMD Down 31 percent in a Month Is This an Indication to Sell the Stock | 01/30/2026 |
8 | Acquisition by Gaugh David Russell of 6304 shares of Amphastar subject to Rule 16b-3 | 02/04/2026 |
9 | 3 Stocks Under 50 with Warning Signs | 02/05/2026 |
10 | Amphastar Pharmaceuticals, Inc. AMPH Shares Bought by New York State Common Retirement Fund - MarketBeat | 02/09/2026 |
11 | Acquisition by Peters William J of 780 shares of Amphastar at 28.41 subject to Rule 16b-3 | 02/13/2026 |
12 | Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 | 02/20/2026 |
| Begin Period Cash Flow | 144.5 M | |
| Total Cashflows From Investing Activities | -124.9 M |
Amphastar | Build AI portfolio with Amphastar Stock |
Amphastar Relative Risk vs. Return Landscape
If you would invest 2,667 in Amphastar P on December 2, 2025 and sell it today you would lose (644.00) from holding Amphastar P or give up 24.15% of portfolio value over 90 days. Amphastar P is currently does not generate positive expected returns and assumes 3.8069% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Amphastar, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Amphastar Target Price Odds to finish over Current Price
The tendency of Amphastar Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 20.23 | 90 days | 20.23 | close to 99 |
Based on a normal probability distribution, the odds of Amphastar to move above the current price in 90 days from now is close to 99 (This Amphastar P probability density function shows the probability of Amphastar Stock to fall within a particular range of prices over 90 days) .
Amphastar Price Density |
| Price |
Predictive Modules for Amphastar
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amphastar P. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Amphastar Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Amphastar is not an exception. The market had few large corrections towards the Amphastar's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amphastar P, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amphastar within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.47 | |
β | Beta against Dow Jones | 1.99 | |
σ | Overall volatility | 1.33 | |
Ir | Information ratio | -0.11 |
Amphastar Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amphastar for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amphastar P can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Amphastar P generated a negative expected return over the last 90 days | |
| Amphastar P has high historical volatility and very poor performance | |
| Over 76.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 |
Amphastar Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amphastar Stock often depends not only on the future outlook of the current and potential Amphastar's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amphastar's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.2 M | |
| Cash And Short Term Investments | 282.8 M |
Amphastar Fundamentals Growth
Amphastar Stock prices reflect investors' perceptions of the future prospects and financial health of Amphastar, and Amphastar fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amphastar Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0547 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.31 B | ||||
| Shares Outstanding | 45.95 M | ||||
| Price To Earning | 972.67 X | ||||
| Price To Book | 1.20 X | ||||
| Price To Sales | 1.31 X | ||||
| Revenue | 719.89 M | ||||
| EBITDA | 149.1 M | ||||
| Cash And Equivalents | 183.39 M | ||||
| Cash Per Share | 3.74 X | ||||
| Total Debt | 47.25 M | ||||
| Debt To Equity | 0.21 % | ||||
| Book Value Per Share | 17.28 X | ||||
| Cash Flow From Operations | 213.39 M | ||||
| Earnings Per Share | 2.26 X | ||||
| Total Asset | 1.63 B | ||||
| Retained Earnings | 666.88 M | ||||
| Current Asset | 175.93 M | ||||
| Current Liabilities | 59.95 M | ||||
About Amphastar Performance
By evaluating Amphastar's fundamental ratios, stakeholders can gain valuable insights into Amphastar's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Amphastar has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amphastar has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Amphastar Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1761 people.Things to note about Amphastar P performance evaluation
Checking the ongoing alerts about Amphastar for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amphastar P help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amphastar P generated a negative expected return over the last 90 days | |
| Amphastar P has high historical volatility and very poor performance | |
| Over 76.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 |
- Analyzing Amphastar's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amphastar's stock is overvalued or undervalued compared to its peers.
- Examining Amphastar's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amphastar's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amphastar's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amphastar's stock. These opinions can provide insight into Amphastar's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |